Skip to content

Efficacy of Nasal strip in patients having Nasal Congestion.

An open Label, Single arm Clinical Study to Evaluate the efficacy of Nasal strip in patients having Nasal Congestion. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/111028
Enrollment
36
Registered
2026-05-25
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Test Product: Nasal Strip: Test Product:Nasal Strip Dose: 1 strip for upto 12 hours Route of Administration: Topical Control Intervention1: Not Applicable: Not Applicable

Sponsors

Piramal Pharma Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject from 18-50 years of age. 2. Subject having Nasal congestion. 3. Subjects that are able to give written informed consent in a manner approved by the institutional ethics committee and comply with the requirements of the study. 4. Subject willing to avoid participation in any other interventional clinical trial for the duration of the study.

Exclusion criteria

Exclusion criteria: 1. Have used, are using, or are planning to use immunosuppressive or immunomodulatory medication (i.e., biologics), including oral or parenteral corticosteroids. 2. Subject with Pollen allergy or nasal allergy. 3. Subjects that have participated in any other interventional clinical trial in the previous 90 days. 4. Subjects with known sensitivity to any of the constituents of the investigational product. 5. Any clinically significant systemic or cutaneous disease, which may interfere with study treatment or procedures. 6. Chronic illness which may influence the outcome of the study. 7. Pregnant/nursing mothers.

Design outcomes

Primary

MeasureTime frame
1. VAS for Nasal congestion 2. SGA Timepoint: At T0min, T24hrs

Secondary

MeasureTime frame
1. PNIF ScoreTimepoint: At T0min, T30min

Countries

India

Contacts

Public ContactPuneet Mittal

CCFT Laboratories

puneetmittal@mgcts.org08937015757

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026